DexCom/ US2521311074 /
9/26/2023 6:15:10 PM | Chg. +1.47 | Volume | Bid6:15:42 PM | Ask6:15:42 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
87.53USD | +1.71% | 109,348 Turnover: 9.48 mill. |
87.51Bid Size: 100 | 94.15Ask Size: 100 | 33.94 bill.USD | - | 99.43 |
GlobeNewswire
12/6/2021
Integrity Applications, Inc. Expands U.S. Operations with the hiring of James P. Thrower, PhD, as Vi...
GlobeNewswire
11/18/2021
Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expa...
GlobeNewswire
10/21/2021
Integrity Applications Announces the Appointment of Paul V. Goode, PhD, as President and Chief Opera...
GlobeNewswire
10/6/2021
Bionano Genomics Expands Commercial Leadership Team to Accelerate Growth of Saphyr® and Bolster Cust...
GlobeNewswire
9/13/2021
iRhythm® Technologies Names Quentin Blackford President and Chief Executive Officer
GlobeNewswire
9/7/2021
GlucoModicum announces the appointment of Peter Gerhardsson as a Senior Advisor
GlobeNewswire
9/7/2021
GlucoModicum announces the appointment of Peter Gerhardsson as a Senior Advisor